ea0029p1634 | Thyroid (non-cancer) | ICEECE2012
Beniko M.
, Ikawa H.
, Mori T.
, Kudo H.
, Matsumoto A.
, Sekiguchi M.
, Mashio Y.
Introduction: According to the guideline for medical treatment of Graves disease by the Japan Thyroid Association in 2011, discontinuation of antithyroid drug is recommended when normal thyroid functions have been maintained for a certain period (≥6 months) after treatment with a minimum maintenance dose (mentioned below). We prospectively studied the remission rates in the patients with Graves disease.Methods: The subjects were 108 pat...